Joel Marcus

Foundation for the National Institutes of Health, Inc. provides healthcare services. It offers services to public health through scientific discovery, translational research and dissemination of research results through public-private partnerships. The organization was founded in 1996 and is headquartered in Bethesda, MD

The Multiple Myeloma Research Foundation, Inc. provides funding for research on myeloma treatment. It provides funding to laboratories worldwide, including compounds and approaches in clinical trials and pre-clinical studies. The firm also facilitates clinical trials through their affiliate organization, the Multiple Myeloma Research Consortium. The company was founded by Karen E. Andrews and Kathryn E. Giusti in 1998 and is headquartered in Norwalk, CT.

Intra-Cellular Therapies, Inc. operates as a biopharmaceutical company. It focuses on the discovery and clinical development of small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms within the central nervous system. The firm’s lead product candidate, ITI-007, is in clinical development as a first-in-class treatment for schizophrenia. It also includes pre-clinical programs that are focused on advancing drug candidates for the treatment of cognitive dysfunction, in both schizophrenia and Alzheimer's disease and for disease modification and the treatment of neurodegenerative disorders, including Alzheimer's disease. The company was founded by Paul Greengard and Sharon Mates in 2002 and is headquartered in Bedminster, NJ.

Citizens United for Research in Epilepsy (CURE) is a non-profit organization that aims to find a cure for epilepsy by promoting and funding patient-focused research. The non-profit company is based in Chicago, IL. CURE has raised over 20 years to fund innovative studies to advance its goal of no seizures and no side effects. The organization has funded more than 270 cutting-edge research projects in 17 countries around the world. CURE sponsors conferences focused on communicating and advancing epilepsy research. The CEO of the company is Beth Dean.

Friends of Cancer Research operates an organization focused on healthcare development. The non-profit company is based in Arlington, VA. The company was founded by Ellen V. Sigal.

The Hamner Institutes for Health Sciences provides medical research services. Its services include preclinical safety, inhalation exposure and aerosol sciences, analytical chemistry and hepatassure services. The firm specializes in Chemical, Drug safety, Toxicology, Global partnership, Translational research, Computational modeling, Genomics, Vivarium and Biosciences Accelerator services. The company was founded in 1974 and is headquartered in Research Triangle Park, NC.

Biohealth Innovation, Inc. sources and evaluates market-relevant bioheath intellectual properties, connects the IP with funding, and assists businesses in marketing and growth. It is a regional innovation intermediary that accelerates and facilitates technology transfer and commercialization of market-relevant research in federal labs, universities, and biohealth companies in the Region. The company was founded in 2011 and is headquartered in Rockville, MD.

Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers.

MeiraGTx Ltd. engages in the development of novel gene therapies to transform the lives of patients suffering from acquired and inherited disorders. The company was founded on March 20, 1991 and is headquartered in London, the United Kingdom.

Lodo Therapeutics Corp. engages in the development of novel therapeutics from its metagenomics-based small molecule discovery platform. Its Lodo platform leverages breakthroughs in next-generation sequencing (NGS), artificial intelligence (AI), and machine learning (ML), along with advances in synthetic biology and automation. The company was founded by Sean Brady and David L. Pompliano and is headquartered in New York, NY.

Petra Pharma Corp. operates as a drug development company that develops novel small molecules for the treatment of cancer and metabolic diseases. The company was founded by Lewis Clayton Cantley and Nathanael S. Gray in 2016 and is headquartered in New York, NY.

AgTech Accelerator Corp. focuses on discovering and developing agricultural technology companies. It offers finance to agricultural firms. The company was founded in 2003 and is headquartered in Durham, NC.

The Partnership for New York City operates as a charitable organization. It is a network of business leaders and corporations working for the economic and cultural betterment of all five boroughs of the city. The firm provides networking opportunities, conducts research, participates in policy making and lobbies government. The company was founded by David Rockefeller in 2002 and is headquartered in New York, NY.

Yumanity, Inc. engages in transforming drug discovery for neurodegenerative diseases services. It provides integrated discovery platforms, phenotypic screening (uHTS) platforms, in which different protein misfolding pathologies are modeled in yeast to help discover compounds to correct these pathologies; a human neuronal platform. The company was founded by Anthony N. Coles, Jr. and Susan L. Lindquist in December 2014 and is headquartered in Boston, MA.

Emerging Technology Partners LLC (ETP) is a venture capital firm founded in 2000 by Wei-Wu He and Bill Snider. The firm is headquartered in San Francisco, California.

Massachusetts Biotechnology Council is a premier life sciences and healthcare hub with over 1,600 members dedicated to preventing, treating, and curing diseases through transformative science and technology. The non-profit company is based in Cambridge, MA. MassBio works to advance policy and promote education while providing member programs, events, industry information, and services. The company's mission is to advance Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system, and improve patient lives. Founded in 1985 by James P. Sherblom, the CEO is Kendalle Burlin O'Connell.

National September 11 Memorial & Museum at the World Trade is a non-profit company based in New York, NY.

NewYorkBIO is an organization that hosts a weekly Virtual Breakfast Series webinar featuring discussions with healthcare leaders. NewYorkBIO is based in New York, NY. The organization offers its members access to various BIO Business Solutions® programs at no cost, and membership with BIO is not required.

Robin Hood Foundation provides grants, strategic support services, and management assistance to community based programs fighting poverty. The firm conducts programs focusing on early childhood development, education, survival, youth, job training, and jobs and economic security. It also offers employment programs, lower income victims' services and relief, mental health services, and other grants. The company was founded by Paul Tudor Jones II in 1988 and is headquartered in New York, NY.

Rodeo Therapeutics Corp. engages in the development of drugs. The firm develops novel small molecules therapies for the treatment of inflammatory bowel disease and the promotion of blood cell reconstitution following bone marrow transplant. It focuses on the development of small-molecule therapies that increase tissue levels of prostaglandin PGE2. The company was founded by Stanton Gerson, Sanford Markowitz, and Joseph Ready on May 15, 2017 and is headquartered in Seattle, WA.

Yumanity Holdings LLC provides healthcare services. The company was founded in 2015 and is headquartered in Cambridge, MA.

Imara, Inc. is a biopharmaceutical company, which engages in the development and commercialization of novel therapeutics to treat patients suffering from hemoglobinopathies. The company was founded by James Gregg McArthur in 2016 and is headquartered in Brookline, MA.

New York Biotechnology Association, Inc. promotes the biotechnology industry. It supports the development and growth of New York State''s life science industry, and serves its members and the life science community by providing a network for public policy, industry advocacy, and community development. The company is headquartered in New York, NY.

Part of Amgen, Inc., Kirin-Amgen, Inc. is a pharmaceutical company that manufactures drugs and provides licensing. The company is based in Thousand Oaks, CA. Kirin-Amgen was acquired by Amgen, Inc. from Kirin Holdings Co., Ltd. on January 29, 2018 for $810 million.

Frequency Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the business of developing therapeutics to activate a person's innate regenerative potential to restore function. The firm is also involved in creating and commercializing therapeutics to potentially transform the lives of individuals by repairing or reversing damage done to cells, tissue, and organs. The company was founded by Robert S. Langer, David L. Lucchino, Christopher R. Loosey, and Will J. McLean on November 13, 2014 and is headquartered in Lexington, MA.

Proniras Corp. operates as a bio technology company. The company is headquartered in Seattle, WA.

AltPep Corp. operates as a biotechnology company that provides platform for tackling amyloid diseases: early diagnostics, disease-modifying therapeutics, and anti-biofilm treatments. The company was founded by Valerie Daggett and Michael Mullan and is headquartered in Mercer Island, WA.

The National Medal of Honor Museum Foundation is dedicated to honoring and preserving the history of the highest military decoration awarded for valor in combat. The non-profit company is based in Mount Pleasant, SC. The museum will provide state-of-the-art, interactive experiences and use the stories of Medal of Honor recipients to inspire and motivate Americans to be their best selves. The foundation will also establish a national monument in the nation's capital to commemorate the service and sacrifice of the bravest and most decorated members of the armed forces. The CEO of the company is Joe Daniels.

The Parker Institute for Cancer Immunotherapy is a research organization that aims to accelerate the development of breakthrough immune therapies to turn all cancers into curable diseases. The Parker Institute for Cancer Immunotherapy is based in San Francisco, CA. The private company conducts clinical trials to tackle the toughest cancers and answer the hardest questions in immunotherapy. The institute coordinates cancer research efforts between the best scientists, clinicians, and partners in the industry. The company has legal experts who help their researchers navigate the intellectual property process and turn their cancer immunotherapy discoveries into treatments. It was founded by Sean N. Parker, Adam Kolom, Michael Polansky.

Alexandria Agtech/Climate Innovation Acquisition Corp. operates as a blank check company. Its objective is effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination. The company was founded on February 18, 2021 and is headquartered in Pasadena, CA.

Yumanity Therapeutics, Inc. is a clinical stage biopharmaceuticals company. It is accelerating the revolution in the treatment of neurodegenerative diseases through its transformative scientific foundation and drug discovery platform. Its platform is based on technology, which enables the rapid screening for novel disease targets and disease modifying drugs that can overcome toxicity in disease-causing gene networks, which usually results from an aberrant accumulation of misfolded proteins in the brain. The company was founded by Susan Lindquist and Tony Coles in December 2014 and is headquartered in Boston, MA.

Équilibre BioPharmaceuticals Corp. is an innovative biopharmaceutical company based in New York, NY. Équilibre BioPharmaceuticals Corp. focuses on identifying and developing high-potential drugs for patients who are treatment resistant or unresponsive to other existing medications. The company's strategy is to leverage their biopharmaceutical industry expertise to expand their portfolio of product opportunities. The company is a patient-focused and science-minded company determined to deliver safe and effective therapies to patients in need. The company was founded by Samuel D. Waksal and the CEO is Philip Barach.

Advisor Partners II LLC (Advisor Partners) is a SEC-registered investment advisor and wealth management firm headquartered in Walnut Creek, California. The firm is related to Pathstone Family Office LLC (Pathstone) as a result of common control and ownership. Pathstone is a multi-family office investment advisory practice owned by Pathstone Holdings LLC. Advisor Partners provides discretionary investment advisory, sub-advisory and consulting services primarily to clients of registered investment advisers (RIA) and financial institutions through two distinct investment programs: Separately Managed Accounts (SMA) and Model Portfolio Consulting (MPC).

The New York City Investment Fund Manager Inc. (The New York City Investment Fund Manager) is a venture capital firm founded in 1996 by Henry Kravis. The firm is headquartered in New York.

Reactive Biosciences Inc. engages in the design and developemnt of novel solutions targeting needs in crop protection, animal health and human health. It specializes in chemistry, research, and biotechnology. The company was founded by Stephen J. Benkovic, Gerald R. Fink, Lucy Shapiro, Paul R. Schimmel and C. Tony Liu in 2015 and is headquartered in Durham, NC.